US Stock MarketDetailed Quotes

OCEL ORGANICELL REGENERATIVE MEDICINE IN

Watchlist
  • 2.750000
  • 0.0000000.00%
15min DelayClose Mar 4 16:00 ET
16.85MMarket Cap-13P/E (TTM)

ORGANICELL REGENERATIVE MEDICINE IN Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ORGANICELL REGENERATIVE MEDICINE IN Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

1.42M

-1.50%
EPS(YoY)

-0.15

+63.31%
Analyst Rating

No Data

ORGANICELL REGENERATIVE MEDICINE IN Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2022/FY6.491M / 10.100M--
DatePeriodRevenue/EstimateEarnings Call
--2022/FY6.491M / 10.100M--

ORGANICELL REGENERATIVE MEDICINE IN Earnings Reports

  • ORGANICELL REGENERATIVE MEDICINE IN | 10-Q: Quarterly report

    Mar 18 16:23 ET

  • ORGANICELL REGENERATIVE MEDICINE IN | 10-K: Annual report

    Jan 29 16:40 ET

    • Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg